Advertisement
U.S. Markets closed

Teladoc Health, Inc. (TDOC)

NYSE - Nasdaq Real Time Price. Currency in USD
15.10-0.17 (-1.11%)
At close: 04:00PM EDT
15.16 +0.06 (+0.40%)
After hours: 07:52PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/29/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
2.52B3.57B3.07B4.17B4.25B3.83B
Enterprise Value
2.99B4.12B3.69B4.87B4.91B4.52B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
0.951.371.201.661.741.64
Price/Book (mrq)
1.081.571.341.821.840.64
Enterprise Value/Revenue
1.156.245.597.477.817.09
Enterprise Value/EBITDA
19.4250.4684.75262.79469.63-1.21

Trading Information

Stock Price History

Beta (5Y Monthly) 0.94
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 330.41
52 Week Low 314.29
50-Day Moving Average 317.48
200-Day Moving Average 320.31

Share Statistics

Avg Vol (3 month) 34.67M
Avg Vol (10 day) 33.32M
Shares Outstanding 5167.04M
Implied Shares Outstanding 6N/A
Float 8165.53M
% Held by Insiders 10.79%
% Held by Institutions 175.85%
Shares Short (Mar 15, 2024) 420.28M
Short Ratio (Mar 15, 2024) 42.87
Short % of Float (Mar 15, 2024) 413.79%
Short % of Shares Outstanding (Mar 15, 2024) 412.14%
Shares Short (prior month Feb 15, 2024) 420.51M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -8.47%
Operating Margin (ttm)-4.53%

Management Effectiveness

Return on Assets (ttm)-3.01%
Return on Equity (ttm)-9.51%

Income Statement

Revenue (ttm)2.6B
Revenue Per Share (ttm)15.81
Quarterly Revenue Growth (yoy)3.60%
Gross Profit (ttm)N/A
EBITDA 46.22M
Net Income Avi to Common (ttm)-220.37M
Diluted EPS (ttm)-1.34
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.12B
Total Cash Per Share (mrq)6.73
Total Debt (mrq)1.6B
Total Debt/Equity (mrq)68.62
Current Ratio (mrq)3.54
Book Value Per Share (mrq)13.96

Cash Flow Statement

Operating Cash Flow (ttm)350.02M
Levered Free Cash Flow (ttm)306M